Literature DB >> 33346539

Surgical Management of Postmastectomy Lymphedema and Review of the Literature.

Kuo Chen1, Mikhail Y Sinelnikov2, Marina A Shchedrina2, Lan Mu3, Pengwei Lu1.   

Abstract

ABSTRACT: Upper limb lymphedema is one of the most common complications after breast cancer surgery and radiotherapy. At present, physical methods and surgical methods can be used for treatment. Surgical operations are mainly based on lymphovenous anastomosis and vascularized lymph node transfer. For these 2 surgical methods, we analyzed and compared the literature review and our own clinical experience. We summarized the differences between the 2 surgical techniques and the selection methods. We hope to help more young plastic surgeons and breast doctors understand how to treat upper limb lymphedema through surgical methods and help patients improve their quality of life.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33346539     DOI: 10.1097/SAP.0000000000002642

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

Review 1.  Cell therapy as a treatment of secondary lymphedema: a systematic review and meta-analysis.

Authors:  Hector Lafuente; Ibon Jaunarena; Eukene Ansuategui; Arantza Lekuona; Ander Izeta
Journal:  Stem Cell Res Ther       Date:  2021-11-20       Impact factor: 6.832

2.  A new severity classification of lower limb secondary lymphedema based on lymphatic pathway defects in an indocyanine green fluorescent lymphography study.

Authors:  Akira Shinaoka; Kazuyo Kamiyama; Kiyoshi Yamada; Yoshihiro Kimata
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 3.  Robot-Assisted Minimally Invasive Breast Surgery: Recent Evidence with Comparative Clinical Outcomes.

Authors:  Kuo Chen; Jin Zhang; Narasimha M Beeraka; Mikhail Y Sinelnikov; Xinliang Zhang; Yu Cao; Pengwei Lu
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.